US 6664230
Orally administered peptides to ameliorate atherosclerosis
expired A61KA61K38/00A61P
Quick answer
US patent 6664230 (Orally administered peptides to ameliorate atherosclerosis) held by The Regents of the University of California expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 61
- CPC classes
- A61K, A61K38/00, A61P, A61P11/00, A61P17/00